[ {
  "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 ],
  "type" : "Negative_regulation",
  "polarity" : false,
  "controller_indices" : [ 6, 7 ],
  "controlled_indices" : [ 23, 24, 25, 26, 27 ],
  "trigger_indices" : [ 10, 11 ],
  "rule_name" : "Negative_regulation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 ],
  "type" : "Negative_regulation",
  "polarity" : false,
  "controller_indices" : [ 6, 7 ],
  "controlled_indices" : [ 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 ],
  "trigger_indices" : [ 10, 11 ],
  "rule_name" : "Negative_regulation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
  "event_indices" : [ 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 ],
  "type" : "Positive_regulation",
  "polarity" : true,
  "controller_indices" : [ 23, 24, 25, 26, 27 ],
  "controlled_indices" : [ 11, 12, 13, 14, 15 ],
  "trigger_indices" : [ 22, 23 ],
  "rule_name" : "Positive_regulation_syntax_3_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
  "event_indices" : [ 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 ],
  "type" : "Positive_regulation",
  "polarity" : true,
  "controller_indices" : [ 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 ],
  "controlled_indices" : [ 11, 12, 13, 14, 15 ],
  "trigger_indices" : [ 22, 23 ],
  "rule_name" : "Positive_regulation_syntax_3_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 ],
  "type" : "Negative_regulation",
  "polarity" : false,
  "controller_indices" : [ 6, 7 ],
  "controlled_indices" : [ 11, 12, 13, 14, 15 ],
  "trigger_indices" : [ 10, 11 ],
  "rule_name" : "Negative_regulation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 ],
  "type" : "Negative_regulation",
  "polarity" : false,
  "controller_indices" : [ 6, 7 ],
  "controlled_indices" : [ 11, 12, 13, 14, 15 ],
  "trigger_indices" : [ 10, 11 ],
  "rule_name" : "Negative_regulation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 ],
  "type" : "Negative_regulation",
  "polarity" : false,
  "controller_indices" : [ 23, 24, 25, 26, 27 ],
  "controlled_indices" : [ 11, 12, 13, 14, 15 ],
  "trigger_indices" : [ 22, 23 ],
  "rule_name" : "Positive_regulation_syntax_3_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 ],
  "type" : "Negative_regulation",
  "polarity" : false,
  "controller_indices" : [ 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 ],
  "controlled_indices" : [ 11, 12, 13, 14, 15 ],
  "trigger_indices" : [ 22, 23 ],
  "rule_name" : "Positive_regulation_syntax_3_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Metformin", "and", "combination", "treatment", "modulate", "signaling", "molecules", "MAPK", "and", "mTOR", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 7, 8 ],
  "trigger_indices" : [ 4, 5 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Metformin", "and", "combination", "treatment", "modulate", "signaling", "molecules", "MAPK", "and", "mTOR", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 9, 10 ],
  "trigger_indices" : [ 4, 5 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Metformin", "alone", "and", "the", "metformin-vemurafenib", "combination", "treatment", "significantly", "decrease", "cell", "viability", "in", "BRAFV600E", "positive", "papillary", "and", "anaplastic", "thyroid", "cancer", "cells", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 9, 10, 11 ],
  "trigger_indices" : [ 8, 9 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
  "event_indices" : [ 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 3, 4 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 7, 8 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 8, 9, 10, 11, 12 ],
  "trigger_indices" : [ 7, 8 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 16, 17 ],
  "trigger_indices" : [ 7, 8 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 7, 8 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
  "event_indices" : [ 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 3, 4 ],
  "controlled_indices" : [ 19, 20 ],
  "trigger_indices" : [ 7, 8 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 6, 7 ],
  "controlled_indices" : [ 16, 17 ],
  "trigger_indices" : [ 7, 8 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11, 12 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 6, 7 ],
  "controlled_indices" : [ 8, 9, 10, 11, 12 ],
  "trigger_indices" : [ 7, 8 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 6, 7 ],
  "controlled_indices" : [ 19, 20 ],
  "trigger_indices" : [ 7, 8 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
  "event_indices" : [ 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 3, 4 ],
  "controlled_indices" : [ 16, 17 ],
  "trigger_indices" : [ 7, 8 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
  "event_indices" : [ 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 3, 4 ],
  "controlled_indices" : [ 8, 9, 10, 11, 12 ],
  "trigger_indices" : [ 7, 8 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 6, 7 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 7, 8 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Combination", "of", "vemurafenib", "and", "metformin", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "both", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "8505c", "anaplastic", "thyroid", "cancer", "cells", "." ],
  "event_indices" : [ 4, 5, 6, 7, 8, 9, 10, 11 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 4, 5 ],
  "controlled_indices" : [ 10, 11 ],
  "trigger_indices" : [ 9, 10 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Combination", "of", "vemurafenib", "and", "metformin", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "both", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "8505c", "anaplastic", "thyroid", "cancer", "cells", "." ],
  "event_indices" : [ 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 2, 3 ],
  "controlled_indices" : [ 10, 11 ],
  "trigger_indices" : [ 9, 10 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "profound", "interaction", "of", "vemurafenib", "and", "rapamycin", "seen", "in", "BCPAP", "cells", "alone", "reflects", "cell", "specific", "sensitivity", "based", "on", "the", "wiring", "pattern", "of", "BRAFV600E", "mediated", "signal", "transduction", "." ],
  "event_indices" : [ 22, 23, 24, 25, 26 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 22, 23 ],
  "controlled_indices" : [ 24, 25, 26 ],
  "trigger_indices" : [ 23, 24 ],
  "rule_name" : "Positive_early_activation",
  "rule" : null
}, {
  "sentence_tokens" : [ "Combination", "of", "vemurafenib", "and", "metformin", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "both", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "8505c", "anaplastic", "thyroid", "cancer", "cells", "." ],
  "event_indices" : [ 4, 5, 6, 7, 8 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 4, 5 ],
  "controlled_indices" : [ 6, 7, 8 ],
  "trigger_indices" : [ 5, 6 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Combination", "of", "vemurafenib", "and", "metformin", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "both", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "8505c", "anaplastic", "thyroid", "cancer", "cells", "." ],
  "event_indices" : [ 2, 3, 4, 5, 6, 7, 8 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 2, 3 ],
  "controlled_indices" : [ 6, 7, 8 ],
  "trigger_indices" : [ 5, 6 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "This", "is", "an", "especially", "appealing", "combination", "because", "of", "the", "widespread", "use", "and", "low", "side", "effects", "of", "metformin", "seen", "in", "patients", "treated", "for", "diabetes", "mellitus", "type", "2.The", "second", "inhibitor", ",", "rapamycin", ",", "directly", "inhibits", "mTOR", "complex", "1", "." ],
  "event_indices" : [ 29, 30, 31, 32, 33, 34 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 29, 30 ],
  "controlled_indices" : [ 33, 34 ],
  "trigger_indices" : [ 32, 33 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Vemurafenib", "binds", "selectively", "to", "the", "active", "site", "of", "BRAFV600E", "protein", ",", "which", "differs", "in", "conformation", "from", "wild-type", "BRAF", ",", "and", "inhibits", "downstream", "MAPK", "signaling", "[", "7", "]", "." ],
  "event_indices" : [ 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 8, 9, 10 ],
  "controlled_indices" : [ 22, 23, 24 ],
  "trigger_indices" : [ 20, 21 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Metformin", "caused", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "BCPAP", "and", "BHP10-3SC", "papillary", "thyroid", "cells", "and", "inhibited", "BHP10-3SC", "tumor", "growth", "in", "nude", "mice", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 3, 4, 5 ],
  "trigger_indices" : [ 1, 2 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Both", "vemurafenib", "and", "metformin", "appear", "to", "have", "anti-cancer", "effects", "in", "thyroid", "cancer", ",", "and", "it", "is", "possible", "that", "adjuvant", "metformin", "therapy", "would", "not", "significantly", "increase", "toxicity", "in", "vemurafenib", "treated", "patients", "due", "to", "its", "high", "safety", "profile", "." ],
  "event_indices" : [ 19, 20, 21, 22, 23, 24, 25, 26, 27, 28 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 19, 20 ],
  "controlled_indices" : [ 27, 28 ],
  "trigger_indices" : [ 24, 25 ],
  "rule_name" : "Positive_activation_syntax_7_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Studies", "involving", "metastatic", "melanoma", "patients", "established", "that", "vemurafenib", "caused", "tumor", "regression", "and", "significantly", "reduced", "risk", "of", "death", "compared", "to", "standard", "dacarbazine", "treatment", ",", "although", "patients", "often", "developed", "resistance", "and", "disease", "progression", "resumed", "after", "6-8", "months", "[", "29", ",", "30", "]", "." ],
  "event_indices" : [ 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 7, 8 ],
  "controlled_indices" : [ 16, 17 ],
  "trigger_indices" : [ 13, 14 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Resistant", "BCPAP", "cells", "in", "this", "assay", "showed", "little", "variability", "in", "apoptosis", ",", "indicating", "that", "although", "combination", "treatment", "with", "metformin", "and", "vemurafenib", "inhibits", "growth", "of", "these", "cells", "(", "Figure", "1C", ")", ",", "it", "does", "not", "cause", "overt", "apoptosis", "that", "can", "be", "detected", "by", "the", "TUNEL", "assay", "[", "28", "]", "(", "Figure", "2A", ",", "2B", ")", "." ],
  "event_indices" : [ 31, 32, 33, 34, 35, 36, 37 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 31, 32 ],
  "controlled_indices" : [ 36, 37 ],
  "trigger_indices" : [ 34, 35 ],
  "rule_name" : "Positive_activation_syntax_1_verb, pronominalMatch",
  "rule" : null
}, {
  "sentence_tokens" : [ "Metformin", "caused", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "BCPAP", "and", "BHP10-3SC", "papillary", "thyroid", "cells", "and", "inhibited", "BHP10-3SC", "tumor", "growth", "in", "nude", "mice", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 7, 8 ],
  "trigger_indices" : [ 1, 2 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Metformin", "caused", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "BCPAP", "and", "BHP10-3SC", "papillary", "thyroid", "cells", "and", "inhibited", "BHP10-3SC", "tumor", "growth", "in", "nude", "mice", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 1, 2 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 19, 20 ],
  "trigger_indices" : [ 7, 8 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "two", "mTOR", "inhibitors", "we", "chose", "are", "both", "clinically", "available", "with", "known", "pharmacokinetics", "and", "with", "somewhat", "differing", "mechanisms", "of", "action.Metformin", "transiently", "inhibits", "the", "respiratory", "chain", "complex", "1", "in", "mitochondria", "and", "this", "leads", "to", "an", "increase", "in", "ratio", "of", "AMP", "to", "ATP", ",", "thereby", "triggering", "activation", "of", "AMP", "activated", "protein", "kinase", "(", "AMPK", ")", ":", "the", "latter", "subsequently", "leads", "to", "mTOR", "inhibition", "[", "39-42", "]", "." ],
  "event_indices" : [ 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 30, 31 ],
  "controlled_indices" : [ 46, 47, 48 ],
  "trigger_indices" : [ 43, 44 ],
  "rule_name" : "Positive_activation_syntax_1_verb, pronominalMatch",
  "rule" : null
}, {
  "sentence_tokens" : [ "While", "these", "studies", "collectively", "point", "out", "the", "therapeutic", "potential", "for", "vemurafenib", ",", "as", "a", "single", "targeted", "therapy", "it", "will", "likely", "not", "be", "able", "to", "prevent", "drug", "resistance", "and", "disease", "progression", "in", "the", "long", "term", "." ],
  "event_indices" : [ 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 17, 18 ],
  "controlled_indices" : [ 25, 26, 27 ],
  "trigger_indices" : [ 24, 25 ],
  "rule_name" : "Negative_activation_syntax_1_verb, pronominalMatch",
  "rule" : null
}, {
  "sentence_tokens" : [ "While", "these", "studies", "collectively", "point", "out", "the", "therapeutic", "potential", "for", "vemurafenib", ",", "as", "a", "single", "targeted", "therapy", "it", "will", "likely", "not", "be", "able", "to", "prevent", "drug", "resistance", "and", "disease", "progression", "in", "the", "long", "term", "." ],
  "event_indices" : [ 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 17, 18 ],
  "controlled_indices" : [ 28, 29, 30 ],
  "trigger_indices" : [ 24, 25 ],
  "rule_name" : "Negative_activation_syntax_1_verb, pronominalMatch",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 8, 9, 10, 11, 12 ],
  "trigger_indices" : [ 2, 3 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 16, 17 ],
  "trigger_indices" : [ 2, 3 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 2, 3 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "two", "mTOR", "inhibitors", "we", "chose", "are", "both", "clinically", "available", "with", "known", "pharmacokinetics", "and", "with", "somewhat", "differing", "mechanisms", "of", "action.Metformin", "transiently", "inhibits", "the", "respiratory", "chain", "complex", "1", "in", "mitochondria", "and", "this", "leads", "to", "an", "increase", "in", "ratio", "of", "AMP", "to", "ATP", ",", "thereby", "triggering", "activation", "of", "AMP", "activated", "protein", "kinase", "(", "AMPK", ")", ":", "the", "latter", "subsequently", "leads", "to", "mTOR", "inhibition", "[", "39-42", "]", "." ],
  "event_indices" : [ 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 30, 31 ],
  "controlled_indices" : [ 40, 41 ],
  "trigger_indices" : [ 31, 32 ],
  "rule_name" : "Positive_activation_syntax_7_verb, pronominalMatch",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "two", "mTOR", "inhibitors", "we", "chose", "are", "both", "clinically", "available", "with", "known", "pharmacokinetics", "and", "with", "somewhat", "differing", "mechanisms", "of", "action.Metformin", "transiently", "inhibits", "the", "respiratory", "chain", "complex", "1", "in", "mitochondria", "and", "this", "leads", "to", "an", "increase", "in", "ratio", "of", "AMP", "to", "ATP", ",", "thereby", "triggering", "activation", "of", "AMP", "activated", "protein", "kinase", "(", "AMPK", ")", ":", "the", "latter", "subsequently", "leads", "to", "mTOR", "inhibition", "[", "39-42", "]", "." ],
  "event_indices" : [ 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 30, 31 ],
  "controlled_indices" : [ 46, 47, 48 ],
  "trigger_indices" : [ 31, 32 ],
  "rule_name" : "Positive_activation_syntax_1_verb, pronominalMatch",
  "rule" : null
}, {
  "sentence_tokens" : [ "Studies", "involving", "metastatic", "melanoma", "patients", "established", "that", "vemurafenib", "caused", "tumor", "regression", "and", "significantly", "reduced", "risk", "of", "death", "compared", "to", "standard", "dacarbazine", "treatment", ",", "although", "patients", "often", "developed", "resistance", "and", "disease", "progression", "resumed", "after", "6-8", "months", "[", "29", ",", "30", "]", "." ],
  "event_indices" : [ 7, 8, 9, 10 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 7, 8 ],
  "controlled_indices" : [ 9, 10 ],
  "trigger_indices" : [ 8, 9 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Metformin", "and", "combination", "treatment", "modulate", "signaling", "molecules", "MAPK", "and", "mTOR", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 7, 8 ],
  "trigger_indices" : [ 5, 6 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Metformin", "and", "combination", "treatment", "modulate", "signaling", "molecules", "MAPK", "and", "mTOR", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 9, 10 ],
  "trigger_indices" : [ 5, 6 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "and", "lenvatinib", "both", "inhibit", "several", "protein", "kinases", "including", "vascular", "endothelial", "growth", "factor", "receptor", "(", "VEGFR", ")", "and", "platelet", "derived", "growth", "factor", "receptor", "(", "PDGFR", ")", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 9, 10, 11, 12, 13 ],
  "trigger_indices" : [ 4, 5 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "and", "lenvatinib", "both", "inhibit", "several", "protein", "kinases", "including", "vascular", "endothelial", "growth", "factor", "receptor", "(", "VEGFR", ")", "and", "platelet", "derived", "growth", "factor", "receptor", "(", "PDGFR", ")", "." ],
  "event_indices" : [ 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 2, 3 ],
  "controlled_indices" : [ 9, 10, 11, 12, 13, 14 ],
  "trigger_indices" : [ 4, 5 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "and", "lenvatinib", "both", "inhibit", "several", "protein", "kinases", "including", "vascular", "endothelial", "growth", "factor", "receptor", "(", "VEGFR", ")", "and", "platelet", "derived", "growth", "factor", "receptor", "(", "PDGFR", ")", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 9, 10, 11, 12, 13, 14 ],
  "trigger_indices" : [ 4, 5 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "and", "lenvatinib", "both", "inhibit", "several", "protein", "kinases", "including", "vascular", "endothelial", "growth", "factor", "receptor", "(", "VEGFR", ")", "and", "platelet", "derived", "growth", "factor", "receptor", "(", "PDGFR", ")", "." ],
  "event_indices" : [ 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 2, 3 ],
  "controlled_indices" : [ 9, 10, 11, 12, 13 ],
  "trigger_indices" : [ 4, 5 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "rapamycin", ":", "FKBP12", "complex", "inhibits", "the", "signal", "transduction", "ability", "of", "mTOR", ",", "preventing", "activation", "of", "multiple", "targets", "required", "for", "progression", "through", "cell", "cycle", "and", "resulting", "in", "G1", "phase", "arrest", "." ],
  "event_indices" : [ 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 3, 4 ],
  "controlled_indices" : [ 11, 12 ],
  "trigger_indices" : [ 5, 6 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "rapamycin", ":", "FKBP12", "complex", "inhibits", "the", "signal", "transduction", "ability", "of", "mTOR", ",", "preventing", "activation", "of", "multiple", "targets", "required", "for", "progression", "through", "cell", "cycle", "and", "resulting", "in", "G1", "phase", "arrest", "." ],
  "event_indices" : [ 3, 4, 5, 6, 7, 8, 9 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 3, 4 ],
  "controlled_indices" : [ 7, 8, 9 ],
  "trigger_indices" : [ 5, 6 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "two", "mTOR", "inhibitors", "we", "chose", "are", "both", "clinically", "available", "with", "known", "pharmacokinetics", "and", "with", "somewhat", "differing", "mechanisms", "of", "action.Metformin", "transiently", "inhibits", "the", "respiratory", "chain", "complex", "1", "in", "mitochondria", "and", "this", "leads", "to", "an", "increase", "in", "ratio", "of", "AMP", "to", "ATP", ",", "thereby", "triggering", "activation", "of", "AMP", "activated", "protein", "kinase", "(", "AMPK", ")", ":", "the", "latter", "subsequently", "leads", "to", "mTOR", "inhibition", "[", "39-42", "]", "." ],
  "event_indices" : [ 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 30, 31 ],
  "controlled_indices" : [ 40, 41 ],
  "trigger_indices" : [ 31, 32, 33 ],
  "rule_name" : "Positive_activation_nested_syntax_2_verb, pronominalMatch",
  "rule" : null
}, {
  "sentence_tokens" : [ "Metformin", "caused", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "BCPAP", "and", "BHP10-3SC", "papillary", "thyroid", "cells", "and", "inhibited", "BHP10-3SC", "tumor", "growth", "in", "nude", "mice", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 18, 19 ],
  "trigger_indices" : [ 16, 17 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 19, 20 ],
  "trigger_indices" : [ 2, 3 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "mTOR", "inhibitors", "sensitize", "thyroid", "cancer", "cells", "to", "cytotoxic", "effect", "of", "vemurafenib", "." ],
  "entity_one_indices" : [ 10, 11 ],
  "entity_two_indices" : [ 0, 1, 2 ]
}, {
  "sentence_tokens" : [ "Vemurafenib", ",", "a", "BRAFV600E", "inhibitor", ",", "has", "shown", "promise", "in", "clinical", "trials", "although", "cellular", "resistance", "occurs", "." ],
  "entity_one_indices" : [ 3, 4, 5 ],
  "entity_two_indices" : [ 0, 1 ]
}, {
  "sentence_tokens" : [ "Changes", "in", "expression", "of", "signaling", "molecules", "such", "as", "decreased", "mTOR", "expression", "in", "BCPAP", "and", "enhanced", "inhibition", "of", "phospho-MAPK", "in", "resistant", "BCPAP", "and", "8505c", "were", "observed", "." ],
  "entity_one_indices" : [ 17, 18 ],
  "entity_two_indices" : [ 9, 10 ]
}, {
  "sentence_tokens" : [ "We", "conclude", "that", "combination", "of", "BRAFV600E", "and", "mTOR", "inhibition", "forms", "the", "basis", "of", "a", "treatment", "regimen", "that", "should", "be", "further", "investigated", "in", "in", "vivo", "model", "systems", "." ],
  "entity_one_indices" : [ 7, 8 ],
  "entity_two_indices" : [ 5, 6 ]
}, {
  "sentence_tokens" : [ "The", "rationale", "behind", "targeting", "BRAFV600E", "kinase", "is", "that", "this", "protein", "is", "specific", "to", "cancer", "cells", "and", "drives", "the", "growth", "promoting", "MAPK", "pathway", "." ],
  "entity_one_indices" : [ 20, 21 ],
  "entity_two_indices" : [ 4, 5, 6 ]
}, {
  "sentence_tokens" : [ "Thyroid", "cancer", "cells", "become", "dependent", "on", "BRAFV600E", "constitutive", "activation", "for", "growth", ",", "survival", ",", "and", "tumor", "progression", "." ],
  "entity_one_indices" : [ 15, 16 ],
  "entity_two_indices" : [ 6, 7 ]
}, {
  "sentence_tokens" : [ "The", "drug", "vemurafenib", "has", "also", "recently", "proved", "to", "be", "useful", "in", "treating", "advanced", "thyroid", "cancer", "patients", "in", "clinical", "trials.In", "an", "earlier", "study", ",", "one", "patient", "with", "metastatic", "thyroid", "cancer", "experienced", "a", "partial", "response", "including", "reduced", "pulmonary", "lesions", "after", "treatment", "with", "vemurafenib", ",", "and", "the", "two", "other", "patients", "had", "stable", "disease", "[", "11", "]", "." ],
  "entity_one_indices" : [ 40, 41 ],
  "entity_two_indices" : [ 2, 3 ]
}, {
  "sentence_tokens" : [ "Brose", "et", "al.", "presented", "results", "of", "an", "ongoing", "phase", "II", "clinical", "study", "for", "vemurafenib", "in", "patients", "with", "metastatic", "or", "unresectable", "BRAFV600E", "positive", "papillary", "thyroid", "cancer", "at", "the", "2013", "ECCO/ESMO/ESTRO", "Annual", "Meeting", "." ],
  "entity_one_indices" : [ 22, 23, 24, 25 ],
  "entity_two_indices" : [ 13, 14 ]
}, {
  "sentence_tokens" : [ "Off-label", "use", "of", "vemurafenib", "for", "17", "patients", "with", "BRAFV600E", "positive", "advanced", "papillary", "thyroid", "cancer", "was", "reviewed", "retrospectively", "and", "found", "to", "be", "effective", "and", "well", "tolerated", "[", "14", "]", "." ],
  "entity_one_indices" : [ 11, 12, 13, 14 ],
  "entity_two_indices" : [ 3, 4 ]
}, {
  "sentence_tokens" : [ "One", "study", "found", "that", "treatment", "with", "metformin", "in", "diabetic", "patients", "with", "thyroid", "cancer", "resulted", "in", "smaller", "tumor", "size", "and", "greater", "chance", "of", "complete", "remission", "[", "17", "]", "." ],
  "entity_one_indices" : [ 16, 17 ],
  "entity_two_indices" : [ 6, 7 ]
}, {
  "sentence_tokens" : [ "As", "expected", ",", "BRAFV600E", "positive", "BCPAP", "papillary", "thyroid", "cancer", "cells", "were", "susceptible", "to", "vemurafenib", "in", "terms", "of", "viability", ",", "which", "was", "decreased", "to", "50", "%", "that", "of", "untreated", "(", "Figure", "1B", ")", "." ],
  "entity_one_indices" : [ 6, 7, 8, 9 ],
  "entity_two_indices" : [ 3, 4 ]
}, {
  "sentence_tokens" : [ "Nthy-ori", "3-1", "braf-wild-type", "thyroid", "cells", "demonstrated", "no", "significant", "changes", "in", "cell", "viability", "in", "response", "to", "any", "of", "the", "treatments", "compared", "to", "untreated", "(", "Figure", "1A", ")", "." ],
  "entity_one_indices" : [ 10, 11, 12 ],
  "entity_two_indices" : [ 3, 4 ]
}, {
  "sentence_tokens" : [ "Interestingly", ",", "vemurafenib", "resistant", "BCPAP", "cells", "also", "appeared", "to", "be", "completely", "resistant", "to", "metformin", ",", "as", "there", "was", "no", "significant", "change", "in", "their", "viability", "in", "response", "to", "treatment", "with", "this", "drug", "as", "a", "single", "agent", "." ],
  "entity_one_indices" : [ 13, 14 ],
  "entity_two_indices" : [ 2, 3 ]
}, {
  "sentence_tokens" : [ "Between", "the", "vemurafenib", "treated", "sample", "and", "the", "metformin", "treated", "sample", "the", "number", "of", "apoptotic", "cells", "detected", "by", "this", "assay", "varied", "only", "slightly", ",", "at", "12.8", "%", "and", "9.33", "%", "of", "total", "cells", ",", "respectively", "." ],
  "entity_one_indices" : [ 7, 8 ],
  "entity_two_indices" : [ 2, 3 ]
}, {
  "sentence_tokens" : [ "Percentage", "of", "apoptotic", "cells", "changed", "very", "little", "between", "untreated", "(", "2.5", "%", ")", "and", "vemurafenib", "treated", "(", "1.6", "%", ")", "samples", "of", "8505c", "anaplastic", "thyroid", "cells", "." ],
  "entity_one_indices" : [ 24, 25 ],
  "entity_two_indices" : [ 14, 15 ]
}, {
  "sentence_tokens" : [ "Metformin", "treated", "8505c", "cells", "demonstrated", "a", "slight", "increase", "in", "apoptosis", "(", "4.8", "%", ")", "." ],
  "entity_one_indices" : [ 9, 10 ],
  "entity_two_indices" : [ 0, 1 ]
}, {
  "sentence_tokens" : [ "Rapamycin", "serves", "as", "a", "direct", "specific", "inhibitor", "of", "mTOR", "." ],
  "entity_one_indices" : [ 8, 9 ],
  "entity_two_indices" : [ 0, 1 ]
}, {
  "sentence_tokens" : [ "We", "found", "the", "percentage", "of", "apoptotic", "cells", "increased", "in", "both", "vemurafenib", "and", "combination", "treatment", "groups", "compared", "to", "untreated", "cultures", "(", "Figure", "5A", ",", "5B", ")", "." ],
  "entity_one_indices" : [ 23, 24 ],
  "entity_two_indices" : [ 10, 11 ]
}, {
  "sentence_tokens" : [ "Concordant", "with", "results", "of", "viability", "assays", ",", "combination", "treatment", "caused", "a", "greatly", "enhanced", "frequency", "of", "apoptosis", "compared", "to", "vemurafenib", "treatment", "alone", "." ],
  "entity_one_indices" : [ 18, 19 ],
  "entity_two_indices" : [ 15, 16 ]
}, {
  "sentence_tokens" : [ "In", "this", "assay", ",", "there", "were", "few", "apoptotic", "cells", "detected", "in", "the", "untreated", "and", "rapamycin", "treated", "BCPAP", "cells", "(", "Figure", "5A", ",", "5B", ")", "." ],
  "entity_one_indices" : [ 22, 23 ],
  "entity_two_indices" : [ 14, 15 ]
}, {
  "sentence_tokens" : [ "BRAF-", "wild-type", "Nthy-ori", "3-1", "cells", "were", "used", "as", "a", "negative", "control", "and", "did", "not", "demonstrate", "appreciable", "apoptosis", "in", "any", "treatment", "group", "(", "Figure", "5A", ",", "5B", ")", "." ],
  "entity_one_indices" : [ 25, 26 ],
  "entity_two_indices" : [ 16, 17 ]
}, {
  "sentence_tokens" : [ "Potent", "inhibitors", "of", "BRAFV600E", ",", "such", "as", "vemurafenib", ",", "show", "great", "promise", "for", "treatment", "of", "BRAFV600E", "positive", "thyroid", "cancer", "." ],
  "entity_one_indices" : [ 15, 16 ],
  "entity_two_indices" : [ 7, 8 ]
}, {
  "sentence_tokens" : [ "BRAFV600E", "mutation", "is", "also", "found", "in", "melanoma", "and", "colorectal", "cancer", "." ],
  "entity_one_indices" : [ 6, 7 ],
  "entity_two_indices" : [ 0, 1, 2 ]
}, {
  "sentence_tokens" : [ "Actions", "of", "metformin", "in", "cancer", "cells", "may", "also", "include", "reducing", "expression", "of", "key", "enzymes", "involved", "in", "fatty", "acid", "synthesis", "as", "well", "as", "membrane", "tyrosine", "kinase", "receptors", "[", "42-44", "]", "." ],
  "entity_one_indices" : [ 16, 17, 18, 19 ],
  "entity_two_indices" : [ 2, 3 ]
}, {
  "sentence_tokens" : [ "If", "changes", "in", "metabolism", "contribute", "to", "resistance", ",", "co-treatment", "with", "agents", "that", "alter", "cellular", "energy", "balance", "may", "hinder", "development", "of", "resistance", "or", "be", "effective", "against", "resistant", "tumors", ",", "as", "suggested", "by", "our", "results", "in", "thyroid", "cancer", "cells", "." ],
  "entity_one_indices" : [ 26, 27 ],
  "entity_two_indices" : [ 3, 4 ]
}, {
  "sentence_tokens" : [ "However", ",", "the", "combination", "treatment", "increased", "BCPAP", "apoptosis", "compared", "to", "vemurafenib", "alone", "without", "a", "significant", "change", "in", "viability", "between", "the", "two", "groups", "." ],
  "entity_one_indices" : [ 10, 11 ],
  "entity_two_indices" : [ 7, 8 ]
}, {
  "sentence_tokens" : [ "A", "likely", "explanation", "is", "that", "decreases", "in", "cell", "viability", "may", "indicate", "decreased", "growth", "rate", "in", "response", "to", "treatment", ",", "in", "addition", "to", "cell", "death", "." ],
  "entity_one_indices" : [ 22, 23, 24 ],
  "entity_two_indices" : [ 7, 8, 9 ]
}, {
  "sentence_tokens" : [ "Thus", ",", "resistant", "BCPAP", "cells", "were", "susceptible", "to", "growth-inhibitory", "effects", "of", "the", "combination", "treatment", ",", "although", "overt", "apoptosis", "was", "not", "detected", "at", "this", "time", "point.It", "should", "be", "noted", "that", "the", "apparent", "discordance", "between", "the", "viability", "and", "apoptosis", "assays", "may", "also", "stem", "from", "the", "different", "end-points", "being", "measuring", "by", "each", "." ],
  "entity_one_indices" : [ 36, 37 ],
  "entity_two_indices" : [ 17, 18 ]
}, {
  "sentence_tokens" : [ "The", "apoptotic", "(", "TUNEL", ")", "assay", "detects", "cells", "with", "fragmented", "DNA", ";", "in", "the", "case", "of", "early-", "or", "mid-", "stage", "of", "apoptosis", "such", "cells", "have", "well", "preserved", "plasma", "membrane", "and", "do", "exclude", "trypan", "blue", "[", "28", "]", "." ],
  "entity_one_indices" : [ 32, 33, 34 ],
  "entity_two_indices" : [ 21, 22 ]
}, {
  "sentence_tokens" : [ "This", "suggests", "a", "role", "for", "metformin", "in", "interfering", "with", "signal", "transduction", "when", "combined", "with", "BRAFV600E", "inhibition", "and", "may", "account", "for", "decreased", "growth", "in", "viability", "assays", "." ],
  "entity_one_indices" : [ 9, 10, 11 ],
  "entity_two_indices" : [ 5, 6 ]
}, {
  "sentence_tokens" : [ "In", "order", "to", "create", "vemurafenib", "resistant", "BCPAP", "cells", ",", "cells", "were", "treated", "for", "24", "hours", "with", "increasing", "concentrations", "of", "vemurafenib", "(", "Chemietek", ",", "Indianapolis", ",", "IN", ")", "up", "to", "16", "mu", "M", ",", "subcultured", "and", "allowed", "to", "grow", "to", "70", "%", "confluence", "before", "the", "next", "treatment", "." ],
  "entity_one_indices" : [ 19, 20 ],
  "entity_two_indices" : [ 4, 5 ]
}, {
  "sentence_tokens" : [ "Cells", "were", "then", "treated", "with", "+/-", "10", "mu", "M", "vemurafenib", "for", "36", "hours", "before", "viable", "cells", "were", "counted", "as", "cells", "unable", "to", "take", "up", "0.4", "%", "trypan", "blue", "solution", "(", "Sigma", ")", "." ],
  "entity_one_indices" : [ 26, 27, 28 ],
  "entity_two_indices" : [ 9, 10 ]
}, {
  "sentence_tokens" : [ "Thyroid", "cells", "were", "plated", "in", "6-well", "plates", "at", "300,000", "cells", "per", "well", "(", "Nthy-ori", "3-1", ",", "BCPAP", ",", "and", "resistant", "BCPAP", ")", "or", "200,000", "cells", "per", "well", "(", "8505c", ")", "and", "allowed", "to", "adhere", "overnight", "." ],
  "entity_one_indices" : [ 13, 14, 15 ],
  "entity_two_indices" : [ 0, 1 ]
}, {
  "sentence_tokens" : [ "BrdU", "incorporated", "into", "DNA", "at", "the", "site", "of", "breaks", "was", "detected", "by", "anti-BrdU", "antibody", "labeled", "with", "Alexa", "Fluor", "488", "dye", "." ],
  "entity_one_indices" : [ 16, 17, 18, 19 ],
  "entity_two_indices" : [ 0, 1 ]
}, {
  "sentence_tokens" : [ "Intensity", "of", "cellular", "fluorescence", "was", "measured", "using", "a", "MoFlo", "XDP", "(", "Beckman-Coulter", ",", "Brea", ",", "CA", ")", "high", "speed", "flow", "cytometer", "and", "sorter", "." ],
  "entity_one_indices" : [ 15, 16 ],
  "entity_two_indices" : [ 9, 10 ]
}, {
  "sentence_tokens" : [ "DAPI", "fluorescence", "was", "excited", "with", "the", "UV", "laser", "(", "355", "nm", ")", ",", "AlexaFluor", "488", ",", "with", "the", "argon", "ion", "(", "488", "nm", ")", "laser", ",", "as", "described", "earlier", "[", "49", "]", "." ],
  "entity_one_indices" : [ 18, 19 ],
  "entity_two_indices" : [ 0, 1 ]
} ]